Apr 28, 2016

Posted by in Stock Reports | 0 Comments

Stocks Seeing Recent Insider Buys: Monsanto Company (NYSE:MON), Novartis AG (ADR) (NYSE:NVS), Eli Lilly and Co (NYSE:LLY)

Stocks Seeing Recent Insider Buys: Monsanto Company (NYSE:MON), Novartis AG (ADR) (NYSE:NVS), Eli Lilly and Co (NYSE:LLY)

As a general rule, insider buying shows management’s confidence in the company, and is considered a bullish sign—in other words a sign that stock prices are likely to go up. Conversely, insider selling is considered bearish—those in the know may be off loading their stocks in an expectation that prices will soon fall. So it pays to keep an eye on the activities of insiders.

Studies have shown that prompt and timely dissemination of insider transactions are profitable for investors, as insiders tend to beat the market. The odds in favor of an insider purchase being followed by further purchases are three times greater than the odds of a purchase followed by a sale.

Moving on to the first insider trade Apr 19, 2016 which involved POSTE GEORGE, a director at Monsanto Company (NYSE:MON), who acquired 1,136 shares at $91.93 per share to put the total holding at 34,619 shares. Its shares currently owned by company management are 0.30% while institutional investors own about 85.10%. The 6-month change recorded in total insider ownership was -1.33%. On the other side, -0.16% change in total institutional ownership has been reported for the 3-month period.

Novartis AG (ADR) (NYSE:NVS) saw an insider buy stock in the company on Apr 12. Novartis Bioventures Ltd, 10% Owner of the company, bought 300,000 shares for $10.00 per share worth a total of $3,000,000. After this insider buying, Novartis Bioventures Ltd now has a total stake of 2,310,924 shares in the company. Its shares currently owned by company management are 9.30% while institutional investors own about 9.80%. The 6-month change recorded in total insider ownership was 0.27%. On the other side, -0.01% change in total institutional ownership has been reported for the 3-month period.

Eli Lilly and Co (NYSE:LLY) also received some insider trading action as LILLY ELI & CO, who is the company’s 10% Owner added some 500,000 shares at a price of $10.00 per share to the holding that now comprises of 2,568,543 shares. Its shares currently owned by company management are 11.80% while institutional investors own about 77.60%. The 6-month change recorded in total insider ownership was -0.99%. On the other side, 0.19% change in total institutional ownership has been reported for the 3-month period.

 

 

 

 

 

Comments are closed.